Picture of Inovio Pharmaceuticals logo

INO — Inovio Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Inovio Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

* Inovio Pharmaceuticals Inc  INO.OQ  reported a quarterly
adjusted loss of $1.12​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of $-2.52.  The mean expectation of
four analysts for the quarter was for a loss of $1.27 per share.
Wall Street expected results to range from $-1.83 to -96 cents
per share.
    * Revenue fell 17.2% to $102.65 thousand from a year ago;
analysts
expected $344.20 thousand. 
    * Inovio Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.12​.
    * The company reported a quarterly loss of $25 million.
    * Inovio Pharmaceuticals Inc shares had risen by 58.2% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 9.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Inovio
Pharmaceuticals Inc is $11.50 
This summary was machine generated from LSEG data March 6 at
11:25 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -1.27          -1.12          Beat
 Sep. 30 2023      -1.52          -1.56          Missed
 Jun. 30 2023      -1.74          -1.56          Beat
 Mar. 31 2023      -1.74          -1.92          Missed

Recent news on Inovio Pharmaceuticals

See all news